Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden.
Department of Drug Treatment, Sahlgrenska University Hospital, Region Västra Götaland, SE-413 45 Gothenburg, Sweden.
Endocrinology. 2022 Oct 23;163(12). doi: 10.1210/endocr/bqac163.
Dehydroepiandrosterone (DHEA), an adrenal androgen precursor, can be metabolized in target tissues into active sex steroids. It has been proposed that DHEA supplementation might result in restoration of physiological local sex steroid levels, but knowledge on the effect of DHEA treatment on local sex steroid levels in multiple tissues is lacking. To determine the effects of DHEA on tissue-specific levels of sex steroids, we treated orchiectomized (ORX) male mice with DHEA for 3 weeks and compared them with vehicle-treated ORX mice and gonadal intact mice. Intra-tissue levels of sex steroids were analyzed in reproductive organs (seminal vesicles, prostate, m. levator ani), major body compartments (white adipose tissue, skeletal muscle, and brain), adrenals, liver, and serum using a sensitive and validated gas chromatography-mass spectrometry method. DHEA treatment restored levels of both testosterone (T) and dihydrotestosterone (DHT) to approximately physiological levels in male reproductive organs. In contrast, this treatment did not increase DHT levels in skeletal muscle or brain. In the liver, DHEA treatment substantially increased levels of T (at least 4-fold) and DHT (+536%, P < 0.01) compared with vehicle-treated ORX mice. In conclusion, we provide a comprehensive map of the effect of DHEA treatment on intra-tissue sex steroid levels in ORX mice with a restoration of physiological levels of androgens in male reproductive organs while DHT levels were not restored in the skeletal muscle or brain. This, and the unexpected supraphysiological androgen levels in the liver, may be a cause for concern considering the uncontrolled use of DHEA.
脱氢表雄酮(DHEA),一种肾上腺雄激素前体,可在靶组织中代谢为活性性激素。有人提出,DHEA 补充可能会导致生理局部性激素水平的恢复,但缺乏关于 DHEA 治疗对多种组织中局部性激素水平影响的知识。为了确定 DHEA 对组织特异性性激素水平的影响,我们用 DHEA 治疗去势雄性小鼠 3 周,并将其与载体处理的去势雄性小鼠和性腺完整的雄性小鼠进行比较。使用灵敏且经过验证的气相色谱-质谱法分析生殖器官(精囊、前列腺、会阴肌)、主要身体隔室(白色脂肪组织、骨骼肌和大脑)、肾上腺、肝脏和血清中的性激素内组织水平。DHEA 治疗将雄性生殖器官中的睾酮(T)和二氢睾酮(DHT)水平恢复到接近生理水平。相比之下,这种治疗并未增加骨骼肌或大脑中的 DHT 水平。在肝脏中,与载体处理的去势雄性小鼠相比,DHEA 治疗使 T 水平(至少增加 4 倍)和 DHT(增加 536%,P < 0.01)大幅增加。总之,我们提供了 DHEA 治疗对去势雄性小鼠组织内性激素水平影响的综合图谱,雄性生殖器官中的雄激素水平恢复到生理水平,而骨骼肌或大脑中的 DHT 水平未恢复。考虑到 DHEA 的不受控制使用,这种情况以及肝脏中出乎意料的超生理雄激素水平可能令人担忧。